Jazz Pharmaceuticals PLC (JAZZ)
Financial leverage ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 12,012,300 | 12,255,700 | 11,361,900 | 11,327,100 | 11,393,400 | 11,204,100 | 11,260,500 | 11,047,100 | 10,835,300 | 10,384,700 | 11,200,100 | 11,768,900 | 12,298,600 | 12,478,200 | 13,213,000 | 6,756,470 | 6,535,900 | 6,291,960 | 6,066,500 | 5,215,300 |
| Total stockholders’ equity | US$ in thousands | 4,093,760 | 4,171,070 | 3,762,600 | 3,696,460 | 3,737,000 | 3,489,370 | 3,525,680 | 3,335,040 | 3,085,730 | 2,745,190 | 3,200,780 | 3,608,490 | 3,965,190 | 3,938,480 | 4,131,490 | 3,797,690 | 3,659,740 | 3,377,200 | 3,141,800 | 2,808,500 |
| Financial leverage ratio | 2.93 | 2.94 | 3.02 | 3.06 | 3.05 | 3.21 | 3.19 | 3.31 | 3.51 | 3.78 | 3.50 | 3.26 | 3.10 | 3.17 | 3.20 | 1.78 | 1.79 | 1.86 | 1.93 | 1.86 |
December 31, 2024 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $12,012,300K ÷ $4,093,760K
= 2.93
The financial leverage ratio of Jazz Pharmaceuticals PLC has shown fluctuations over the periods from March 31, 2020, to December 31, 2024. The ratio started at 1.86 in March 2020, indicating a moderate level of leverage, and increased gradually to 3.50 by June 30, 2022. This significant increase in leverage suggests a higher proportion of debt in the company's capital structure.
Subsequently, the financial leverage ratio fluctuated between 3.50 and 2.93 until December 31, 2024. This level of financial leverage indicates that Jazz Pharmaceuticals PLC is relying more on debt to finance its operations and growth opportunities. A higher financial leverage ratio signifies a higher financial risk due to increased debt obligations, which can impact the company's financial stability and flexibility.
It is essential for Jazz Pharmaceuticals PLC to carefully manage its debt levels and ensure that the increased leverage does not hinder its ability to meet its financial obligations or pursue future investments. Monitoring the financial leverage ratio over time can provide insights into the company's capital structure and financial risk profile, aiding stakeholders in assessing the company's overall financial health.
Peer comparison
Dec 31, 2024